Tumour Necrosis Factor Synergises with Gamma Interferon on the Induction of mRNA for DR Alpha Chain on Thyrocytes from Graves' Disease and Non Toxic Goitre

References

• Hanafusa T, Pujol-Borrell R, Choivato L, Russell R CG, Doniach D, Bottazzo G F. Aberrant expression of HLA-DR antigen on thyroeytes in Graves' Disease: relevance for autoimmunity. Lancet 1983; ii: 1111–1115
   Google Scholar
• Bottazzo G F, Pujol-Borrell R, Hanafusa T, Feldmann M. Hypothesis: Role of aberrant HLA-DR expression and antigen presentation in the induction of endocrine autoimmunity. Lancet 1983; ii: 1115–1119
   Google Scholar
• Todd I, Pujol-Borrell R, Hammond L J, Bottazzo G F, Feldmann M. Interferon-γ induces HLA-DR expression by thyroid epithelium. Clin Exp Immunol 1985; 61: 265–273
   PubMed Web of Science ®Google Scholar
• Todd I, Pujol-Borrell R, Hammond L J, McNally J M, Feldmann M, Bottazzo G F. Enhancement of thyrocyte HLA class II expression by thyroid stimulating hormone. Clin Exp Immunol 1987a; 69: 524–531
   PubMed Web of Science ®Google Scholar
• Todd I, Pujol-Borrell R, Belfiore A, Bottazzo G F. Thyroeytes HLA class II expression and regulation in relation to thyroid autoimmunity. Acta Endocrinol 1987b; 115(Suppl. 281)27–34
   Google Scholar
• Pujol-Borrell R, Todd I, Doshi M, Bottazzo G F, Sutton R, Gray D, Adolf G R, Feldmann M. HLA class II induction in human islet cells by Interferon-γ plus tumour necrosis factor or lymphotoxin. Nature 1987; 326: 403–306
   Google Scholar
• Turner M, Londei M, Feldmann M. Human T cells from autoimmune and normal individuals can produce tumour necrosis factor. Eur J Immunol 1987; 17: 1807–1814
   PubMed Web of Science ®Google Scholar
• Grubeck-Loebenstein B, Derfler K, Kassal H, Knapp W, Krish K, Liszka K, Smith P PA, Waldhausl W. Immunological features of nonimmunogenic hyperthyroidism. J Clin Endocrinol Metab 1985; 60: 150–155
   PubMed Web of Science ®Google Scholar
• Londei M, Lamb J R, Bottazzo G F, Feldmann M. Epithelial cells expressing aberrant MHC Class II determinants can present antigen to cloned human T cells. Nature 1984; 312: 639–641
   PubMed Web of Science ®Google Scholar
• White B A, Bancroft F C. Cytoplastatic dot hybridization. J Biol Chem 1982; 257: 8569–8572
   PubMed Web of Science ®Google Scholar
• Kissonerghis M, Maini R N, Feldmann M. High rate of HLA class II mRNA synthesis in rheumatoid arthritis joints and its persistence in culture: down regulation by recombinant IL-2. Scand J Immunol 1989; 29: 73–82
   PubMedGoogle Scholar
• Maniatis T, Fritsch E F, Sambrook J. Molecular cloning. A Laboratory manual. Cold Spring Harbor Laboratory Press, N.Y. 1982
   Google Scholar
• Lee J S, Trowsdale J, Bodmer W F. cDNA clones coding for the heavy chain of the human HLA-DR antigen. Proc Natl Acad Sci USA 1982; 79: 545–549
   PubMed Web of Science ®Google Scholar
• Kaczmarek L, Calabretta B, Baserga R. Expression of cell cycle dependent genes in phytohaemag-glutinin stimulated human lymphocytes. Proc Natl Acad Sci USA 1985; 82: 5375–5379
   PubMedGoogle Scholar
• Feinberg A P, Vogelstein B. A technique for radiolabelling DNA restriction endonuclease fragments to higher specific activity. Anal Biochem 1983; 132: 6–13
   PubMed Web of Science ®Google Scholar
• Buchan G S, Barrett K, Fujita T, Taniguchi T, Maini R N, Feldmann M. Detection of activated T cell products in the rheumatoid joint using cDNA probes to interleukin 2, IL-2 receptor and interferon γ. Clin Exp Immunol 1988; 71: 295–301
   PubMed Web of Science ®Google Scholar
• Feldmann M. Regulation of HLA class II expression and its role in autoimmune disease. Autoimmunity and autoimmune disease. Wiley, Chichester 1987; 88–108, (Ciba Foundation Symposium 129)
   Google Scholar
• Bottazzo G F, Dean B M, McNally J M, Mackay E H, Swift M A, Gamble D R. In situ characterization of autoimmune phenomena and expression of HLA molecules in the pancreas in diabetic insulitis. N Engl J Med 1985; 313: 353–360
   PubMed Web of Science ®Google Scholar
• Londei M, Bottazzo G F, Feldmann M. Human T-cell clones from autoimmune thyroid glands: specific recognition of autologous thryoid cells. Science 1985; 228: 85–89
   PubMed Web of Science ®Google Scholar
• Grubeck-Loebenstein B G, Londei M, Greenall C, Pirich K, Kassal H, Waldhausl W, Feldmann M. Pathogenetic relevance of HLA class II expressing thryoid follicular cells in non toxic goiter and in Graves' disease. J Clin Invest 1988; 81: 1608–1614
   PubMed Web of Science ®Google Scholar
• LLoyd R V, Johnson T L, Blaivas J, Sisson J C, Wilson B S. Detection of HLA-DR antigens in paraffin-embedded thyroid epithelial cells with a monolconal antibody. Am J Pathol 1985; 120: 106–111
   Google Scholar
• Piccinini L A, Schachter B S, Davies T F. HLA-DRα chain expression in human thyroid. Endocrinology 1986; 118: 2611–2613
   Google Scholar
• Piccinini L A, Mackenzie W A, Platzer M, Davies T. Lymphokine regulation of HLA-DR gene expression in human thyroid cell monolayers. Journal of Clinical Endocrinology and Metabolism 1987; 64: 543–548
   PubMed Web of Science ®Google Scholar
• Platzer M, Neufeld D S, Piccinini L A, Davies T F. Induction of rat thyroid cell MHC class II antigen by thyrotropin and y-interferon. Endocrinology 1987; 121: 2087–1092
   PubMedGoogle Scholar
• Steeg P S, Moore R N, Johnson H M, Oppenheim J J. Regulation of murine macrophage Ia antigen expression by lymphokine with Immune Interferon activity. J Exp Med 1982; 156: 1780
   PubMedGoogle Scholar
• Weetman A P, Volkman D J, Burman K D, Gerrard T L, Fauci A S. The in vitro regulation of human thyrocyte HLA-DR antigen expression. J Clin Endorcrin Metab 1985; 61: 817–824
   PubMed Web of Science ®Google Scholar
• Old L J. Tumor necrosis factor (TNF). Science (Washington DC) 1985; 230: 630
   PubMed Web of Science ®Google Scholar
• Pfizenmaier K, Scheurich P, Schluter C, Kronke M. Tumour necrosis factor enhances HLA-A, B, C and HLA DR gene expression in human tumour cells. J Immunol 1987; 138: 975–980
   PubMed Web of Science ®Google Scholar
• Londei M, Grubeck-Loebenstein B, Kissonerghis M, Austin P, Trowsdale J, Greenall C, Feldmann M. Thyrocytes can synthesize HLA class II molecules. Acta Endocrinologica 1987; 115(Suppl. 281)82–85
   Google Scholar
• Altmann D M, Hogg N, Trowsdale J, Wilkinson D. Cotransfection of ICAM-1 and HLA-DR reconstitutes human antigen-presenting cell function in mouse L cells. Nature 1989; 338: 512–514
   PubMed Web of Science ®Google Scholar
• Trinchieri G, Perussia B. Immune interferon: a pleitropic lymphokine with multiple effects. Immunol Today 1985; 6: 131–136
   PubMedGoogle Scholar